Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$843K Sell
7,052
-865
-11% -$113K 0.03% 371
2025
Q4
$1.08M Buy
7,917
+12
+0.2% +$1.73K 0.04% 325
2025
Q3
$1.17M Sell
7,905
-149
-2% -$20.7K 0.04% 311
2025
Q2
$1.04M Hold
8,054
0.04% 313
2025
Q1
$962K Hold
8,054
0.04% 313
2024
Q4
$934K Hold
8,054
0.04% 306
2024
Q3
$1.09M Hold
8,054
0.05% 299
2024
Q2
$1.09M Buy
8,054
+4,195
+109% +$571K 0.05% 284
2024
Q1
$499K Buy
+3,859
New +$466K 0.02% 413

Other funds holding XYL

Argent Trust Co's XYL Position: Q1 2026 in Review

Argent Trust Co reduced its Xylem (XYL) stake by 11% in Q1 2026, selling an estimated $113K and leaving 7,052 shares worth $843K. The position accounts for 0.03% of the portfolio, ranked #371.

Argent Trust Co first reported a position in XYL in Q1 2024 and has held it in 9 quarters since. The position peaked at $1.17M in Q3 2025. 1,107 funds tracked by Wall St. Rank hold XYL as of Q1 2026.

  • Argent Trust Co held 7,052 shares of Xylem worth $843K as of Q1 2026.
  • Argent Trust Co sold 865 Xylem shares in Q1 2026, an estimated $113K.
  • Xylem made up 0.03% of Argent Trust Co's portfolio in Q1 2026, its #371 holding.
  • Argent Trust Co first reported a position in Xylem in Q1 2024 and has held it in 9 quarters since.
  • Argent Trust Co's Xylem position peaked at $1.17M in Q3 2025.
  • 1,107 funds tracked by Wall St. Rank held Xylem as of Q1 2026.

Based on Argent Trust Co's 13F filing for Q1 2026, filed 13 May 2026.